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Abstract
 
gp49B1 is expressed on mast cells and inhibits immunoglobulin E–dependent activation and
inflammation in vivo. We now show that gp49B1 is expressed on neutrophils and prevents
neutrophil-dependent vascular injury in response to lipopolysaccharide (LPS). The intradermal
(i.d.) injection of LPS into gp49B1-null (
 
gp49B
 
 
 
/
 
 
 
) but not gp49B1-sufficient (
 
gp49B
 
 
 
/
 
 
 
)
mice elicited macroscopic hemorrhages by 24 h, which were preceded on microscopic analyses
by significantly more intravascular thrombi (consisting of neutrophils, platelets, and fibrin) that
occluded venules and by more tissue neutrophils than in 
 
gp49B
 
 
 
/
 
  
 
mice. However, there were
no differences in the number of intact (nondegranulating) mast cells or the tissue levels of mediators
that promote neutrophil recruitment. Hemorrhage was prevented by depleting neutrophils,
blocking 
 
 
 
2 integrin–intercellular adhesion molecule 1 interactions, or inhibiting coagulation.
 
These characteristics indicate that 
 
gp49B
 
 
 
/
 
  
 
mice are exquisitely sensitive to a local Shwartzman
reaction (LSR) after a single i.d. injection of LPS, whereas in the classic LSR, a second exposure
is required for increased 
 
 
 
2 integrin function, intravascular neutrophil aggregation, formation
of occlusive thrombi, and hemorrhage. Moreover, LPS increased gp49B1 expression on neutrophils
in vivo. The results suggest that gp49B1 suppresses the LPS-induced increase in intravascular
neutrophil adhesion, thereby providing critical innate protection against a pathologic response
to a bacterial component.
Key words: Shwartzman reaction • thrombosis • hemorrhage • cell adhesion molecules • 
innate immunity
 
Introduction
 
A rapid inflammatory response to pathogenic microbes and
their products is essential for the survival of all higher organ-
isms. This response is mediated largely by the innate immune
system through cells that reside constitutively in tissues,
such as macrophages and mast cells, as well as by neutro-
phils that migrate from the blood to a site of invasion
within hours (1–3). These cells are activated by pattern
recognition receptors, such as the Toll-like receptors
(TLRs), and by receptors that bind endogenous products
formed in response to infection, such as receptors for certain
complement fragments (4, 5). These innate receptors are
encoded in the germline and hence are either expressed
constitutively or induced rapidly in response to microbes or
microbial products. This characteristic delineates the innate
receptors from the elements of adaptive immunity, in
which humoral and cellular defenses are generated over
days to weeks through antigen-induced recombination of
T cell receptors and B cell receptors/Ig genes followed by
clonal expansion of the selected cells.
Despite the essential nature of innate inflammation, an
overly vigorous response can be detrimental (6) as, for exam-
ple, when toxic levels of cytokines such as TNF-
 
  
 
and IL-1
 
 
 
are produced and cause septic shock leading to multiple organ
failure (7). Therefore, it seemed reasonable to speculate that
the cells that mediate innate inflammation might express
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Abbreviations used in this paper:
 
 Alexa, Alexa Fluor 488; ICAM, intercellular
adhesion molecule; i.d., intradermal; ITIM, immunoreceptor tyrosine-
based inhibitory motif; LSR, local Shwartzman reaction; MCP, monocyte
chemotactic protein; MIP, macrophage inflammatory protein; SCF, stem
cell factor; TLR, Toll-like receptor.T
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inhibitory receptors that can counterregulate the activation
responses. We have previously shown that gp49B1, which
is expressed constitutively on the surface of mouse mast
cells and macrophages (8, 9), inhibits the high affinity re-
ceptor for IgE (Fc
 
 
 
RI)-dependent activation of mast cells
in vitro through recruitment of the 
 
src
 
 homology type 2
domain-containing phosphatase 1 to the immunoreceptor
tyrosine-based inhibitory motifs (ITIMs) located in the cy-
toplasmic domain of gp49B1 (10). Moreover, we deter-
mined that gp49B1 dampens Fc
 
 
 
RI-dependent mast cell
activation and the resulting immediate inflammatory re-
sponse in vivo in gp49B1-sufficient (
 
gp49B
 
 
 
/
 
 
 
) mice as
compared with gp49B1-null (
 
gp49B
 
 
 
/
 
 
 
) mice (11). We
subsequently found that mast cells in 
 
gp49B
 
 
 
/
 
  
 
mice are
also more sensitive to activation induced by the cytokine
stem cell factor (SCF; reference 12), which signals through
its receptor c-
 
kit 
 
(13). This finding revealed that the inhibi-
tory capacity of gp49B1 extends beyond receptors of adap-
tive immunity, and it raised the possibility that the germ-
line-encoded gp49B1 also suppresses inflammation induced
by ligands that stimulate innate immune responses.
To address this issue, we compared the responses of
 
gp49B
 
 
 
/
 
  
 
and 
 
gp49B
 
 
 
/
 
  
 
mice to LPS derived from 
 
Esche-
richia coli
 
, which activates cells through TLR4 (4). We
found that the intradermal (i.d.) injection of LPS in
 
gp49B
 
 
 
/
 
  
 
mice elicited the formation of thrombi and
hemorrhages in a manner fully dependent on neutrophils,
 
 
 
2 integrins, intercellular adhesion molecule (ICAM)-1,
and coagulation. This response was suppressed in 
 
gp49B
 
 
 
/
 
 
 
mice. The thrombohemorrhagic response of 
 
gp49B
 
 
 
/
 
 
 
mice to LPS is reminiscent of the classic local Shwartzman
reaction (LSR), in which an initial dermal exposure to
LPS primes the skin for a thrombohemorrhagic vasculopa-
thy in response to systemic challenge with LPS 18–24 h
later (14). The first, local exposure increases expression of
ICAM-1 on endothelial cells, and the second, systemic
dose increases and prolongs 
 
 
 
2 integrin expression and
avidity on neutrophils (15). This sequence leads to patho-
logic adhesion of neutrophils to each other and to the en-
dothelium, resulting in thrombus formation and hemor-
rhage (15). Here we show that neutrophils constitutively
express gp49B1 and that in 
 
gp49B
 
 
 
/
 
  
 
but not in 
 
gp49B
 
 
 
/
 
 
 
mice the expression increases in response to LPS over a
time course that precedes the development of the throm-
bohemorrhagic response in 
 
gp49B
 
 
 
/
 
  
 
mice. Our findings
reveal that in the absence of gp49B1 on neutrophils, an in-
crease in sensitivity to LPS makes a single exposure suffi-
cient to elicit an LSR, possibly at the 
 
 
 
2 integrin–ICAM-1
interaction step. Thus, gp49B1 constitutively inhibits a
pathologic response to a microbial product that stimulates
the innate immune system.
 
Materials and Methods
 
Mice.
 
Male 
 
gp49B
 
 
 
/
 
  
 
and 
 
gp49B
 
 
 
/
 
  
 
mice (N9 backcrossed to
the BALB/c strain) were produced as previously described (11)
and were 6–11-wk old when used for experiments. Mice were
maintained in a specific pathogen-free barrier facility at the Dana-
 
Farber Cancer Institute, and the studies were approved by the
Animal Care and Use Committee.
 
Preparation of LPS.
 
LPS purified from 
 
E. coli
 
 0111:B4 by phe-
nol extraction and ion exchange chromatography (
 
 
 
1% protein;
Sigma Ultra L-3024, lot 111k4046) was purchased from Sigma-
Aldrich. 25 mg LPS was suspended in 10 ml endotoxin-free saline
(Sigma S8776, lot 111K2351). After gentle mixing, the LPS solu-
tion was warmed to 37
 
 
 
C in a water bath for 30 min and then
sonicated for 2 min in an ultrasonic water bath (Branson Sonifier
450; VWR Scientific) to increase the solubility. This LPS stock
solution was then aliquoted into 0.5-ml Eppendorf tubes and
stored at 
 
 
 
20
 
 
 
C. For use, the LPS solution was warmed to 37
 
 
 
C
for 30 min and sonicated for 2 min.
 
Antibodies.
 
Unlabeled and PE-labeled rat IgG2b anti–mouse
Gr-1 mAb (clone RB6-8C5), rat IgG2a anti–mouse CD18 mAb
(clone M18/2), rat IgG2a negative control mAb (clone eBR2a),
rat IgG2b anti–mouse CD54 mAb (clone YN1/1.7.4), and rat
IgG2b negative control mAb (clone KLH/G2b-1-2) were ob-
tained from eBioscience (all non–PE-labeled Abs were functional
grade). PE-labeled rat IgG2b negative control mAb (clone A95-1;
BD Biosciences) and rat IgM negative control mAb (clone
IR202; Zymed Laboratories) were obtained as noted. The rat
IgM anti–mouse gp49B1 mAb B23.1 (8, 16) was produced in the
ascites fluid of 
 
nu/nu
 
 mice and purified with the ImmunoPure
IgM purification kit (Pierce Chemical Co.). Purified mAb B23.1
and rat IgM negative control were labeled with the Alexa Fluor
488 (Alexa) protein labeling kit (Molecular Probes, Inc.) accord-
ing to the product instructions.
 
Tissue Thickness, Histologic, and Cytokine/Chemokine Analyses of
LPS-induced Inflammation.
 
50 
 
 
 
g LPS in 20 
 
 
 
l saline was in-
jected i.d. in the right ear of each mouse with a 25-
 
 
 
l Hamilton
syringe (Hamilton Company) fitted with a 30G 1/2 gauge needle
(Becton Dickinson). 20 
 
 
 
l saline was injected in the left ear as a
negative control. At various times after the injection, ear thick-
ness was measured with a caliper as previously described (12). Ad-
ditional mice were killed by CO
 
2 
 
inhalation, and to record hem-
orrhages macroscopically, photographs of the entire bodies or ears
of mice were taken with a digital camera (Coolpix 5000; Nikon).
The ears were then excised, fixed in 4% paraformaldehyde for at
least 8 h, and embedded in JB-4 glycolmethacrylate. 2-
 
 
 
m-thick
full-length cross sections of ears were cut, placed on microscope
slides, air dried, and stained with Diff-Quik to count mast cells
(12) or for chloroacetate esterase activity to count neutrophils and
thrombi. The number of cells and thrombi in each full-length
cross section was divided by the number of lengths in the section
to obtain the number of cells or thrombi per unit length. Occlud-
ing thrombi were defined as those blocking 100% of the diameter
of blood vessels.
For the measurement of cytokines and chemokines 2 h after
LPS injection (the time of maximal generation in pilot time course
experiments), the ears were excised, weighed, and placed in a
buffer consisting of calcium- and magnesium-free HBSS contain-
ing 1% NP-40, 10 mM Hepes, pH 7.2, 5 
 
 
 
M leupeptin, 5 
 
 
 
M
pepstatin A, 200 
 
 
 
M 4-(2-aminoethyl)-benzenesulfonyl fluoride,
and 20 
 
 
 
M aprotinin (all reagents were obtained from Sigma-
Aldrich except NP-40, which was obtained from BDH Limited).
The tissue was homogenized for 2 min at 4
 
 
 
C in a Minibead-
beater-8 Cell Disruptor (BioSpec Products, Inc.) at setting 2. The
homogenates were centrifuged at 14,000 rpm for 30 min at 4
 
 
 
C in
a Hermle Labnet Z233M microfuge. The supernatants were aspi-
rated and additional insoluble material was removed by centrifuga-
tion of the supernatants at 4,000 rpm for 10 min at 4
 
 
 
C through
0.22 
 
 
 
m cellulose acetate filters in SPIN-X
 
® 
 
centrifuge tubes (Co-T
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star). The amounts of IL-1
 
 
 
, KC, monocyte chemotactic protein
(MCP)-1, macrophage inflammatory protein (MIP)-1
 
 
 
, MIP-2,
and TNF-
 
 
 
 in the filtered extracts were measured with Quanti-
kine
 
® 
 
M colorimetric sandwich ELISA kits (R&D Systems) accord-
ing to the manufacturer’s instructions. Data were calculated as
picograms of mediator per milligram of ear tissue.
 
Collection of Blood Samples and Analysis of Peripheral Blood Leuko-
cytes.
 
Mice were injected with either LPS or saline as described
above. At the times indicated below, mice were killed by CO
 
2 
 
in-
halation, and blood was obtained by cardiac puncture with a 1-ml
syringe that had been washed with 0.1 ml of 0.5 M EDTA solu-
tion (E-7889; Sigma-Aldrich). The blood was placed in a 2-ml
Vacutainer
 
® 
 
tube containing 3.6 mg dry dipotassium EDTA
(Becton Dickinson), and within 30 min, samples (
 
 
 
500 
 
 
 
l) were
analyzed for leukocyte count and differential on an automatic cell
counter (ADVIA
 
® 
 
120A; Bayer Diagnostics) in the Hematology
Laboratory of Children’s Hospital Boston.
 
Neutrophil Depletion and Blocking of Adhesion Molecules.
 
To
deplete neutrophils, 100 
 
 
 
g anti–Gr-1 was injected i.p. 24 h be-
fore the i.d. injection of LPS (50 
 
 
 
g/ear) and saline in the right
and left ears, respectively. The injection of mice with anti–Gr-1
does not deplete T or B lymphocytes, mononuclear phagocytes,
or NK cells (17). To block the 
 
 
 
2 chain of integrins (CD18) or
ICAM-1 (CD54), 100 
 
 
 
g anti-CD18 or 100 
 
 
 
g anti-CD54 was
injected i.v. 2 h before the i.d. injection with LPS (35 
 
 
 
g/ear)
and saline in separate ears. Control animals were injected i.v. with
100 
 
 
 
g isotype-matched negative control mAb, or saline before
the i.d. injection of LPS or saline.
 
Anticoagulant Treatment. gp49B
 
 
 
/
 
  
 
mice received 2 mg
(in 200 
 
 
 
l) warfarin [3-(
 
 
 
-acetonylbenzyl)-4-hydroxycoumarin]
(Sigma-Aldrich) or vehicle control (15% acetone in pyrogen-free
water; Sigma-Aldrich) by stomach tube 1 h before and 2 h after
the i.d. injection of LPS (25 
 
 
 
g/ear) and saline in the right and
left ears, respectively. The LPS dose was reduced somewhat for
Figure 1. LPS-induced hemorrhage, thrombosis, and tissue neutrophilia in gp49B    and gp49B    mice. gp49B /  and gp49B /  mice were injected
i.d. with 20  l saline alone (left ears) or containing 50  g LPS (right ears). At the times indicated below, the mice were killed and their ears were
removed, photographed, placed in fixative, embedded, and sectioned for staining with chloroacetate esterase. (A) The macroscopic appearance of the ears
of three mice of each genotype 24 h after the injection of saline or LPS is shown from one experiment, representative of five experiments with a total of
15 gp49B /  and 31 gp49B /  mice. (B and C) Microscopic fields of tissue sections 12 (B) and 24 h (C) after the injection of LPS (a–c and e–g) or saline
(d and h) show the extent of hemorrhage (a and e), thrombi (b and f), and tissue neutrophilia (c and g). In g, an area with minimal hemorrhage is shown
to permit visualization of the neutrophils, which stain red with chloroacetate esterase. The data are representative of two (12 h) and three (24 h) experiments
with 7 and 10 mice, respectively, of each genotype per time point. (D) The number of neutrophils in full-length tissue cross sections was enumerated and
is expressed per microscopic unit length (140  m) as mean   SEM, n   3 (2 and 6 h) and n   7 (12 and 24 h). *, significant difference between gp49B / 
and gp49B /  mice.T
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the studies with anti-adhesion molecule antibodies and the anti-
coagulant to illustrate better the effects of these interventions on
macroscopic hemorrhage.
Flow Cytometric Analyses. Samples of whole blood (400  l)
collected as described above were mixed with 7 ml ACK lysis
buffer (155 mM NH4Cl, 10 mM KHCO3, 111  M disodium
EDTA in Milli-Q water; all reagents from Sigma-Aldrich) and
incubated at room temperature for 10 min. 7 ml HBA buffer (cal-
cium- and magnesium-free HBSS containing 0.1% [wt/vol] BSA
and 0.02% [wt/vol] sodium azide) was added, and samples were
mixed well and centrifuged for 5 min at 1,000 rpm (Beckman
GPR Centrifuge) at 4 C. The pelleted leukocytes were washed
once by centrifugation in 10 ml HBA buffer, resuspended in 500
 l HBA buffer, and adjusted to 106 cells/ml. Bone marrow cells
were isolated by flushing the femurs and tibias of mice with
RPMI 1640 medium, and cells were resuspended as described for
blood leukocytes. 100- l portions of cells were distributed into
the wells of a 96-well round-bottom cell culture plate (Costar
3799), and incubated for 30 min at 4 C with saturating concen-
trations of Alexa-labeled mAb B23.1, PE-labeled anti–Gr-1, or
equal concentrations of isotype-matched negative control mAb.
The cells were then washed in HBA buffer twice and analyzed on
a FACSort™ with CELLQuest™ software (Becton Dickinson).
The neutrophil population was identified on the basis of the anti–
Gr-1 staining, and the mAb B23.1 positivity was measured on
that cell population.
Statistical Analyses. Data are expressed as mean   SEM unless
otherwise noted. Differences between groups of mice were as-
sessed with Student’s unpaired, two-tailed t test. P values  0.05
were defined as statistically significant.
Results
LPS-induced Hemorrhage, Thrombosis, and Tissue Neutro-
philia in gp49B    Mice. The right ears of gp49B /  and
gp49B /  mice were injected i.d. with 50  g LPS in 20
 l endotoxin-free sterile saline, and the left ears were in-
jected with an equal volume of saline alone. 24 h (but not
12 h) after injection of LPS, gp49B /  mice exhibited
moderate to severe macroscopic hemorrhage in ears in-
jected with LPS, whereas gp49B /  mice did not (illus-
trated for three mice from a representative experiment in
Fig. 1 A). In a series of experiments, 26 of 31 (84%)
gp49B /  mice exhibited a macroscopic hemorrhagic re-
sponse 24 h after the injection of LPS, compared with
only 1 of 15 (7%) gp49B /  mice. Histologic analysis con-
firmed that no hemorrhage had occurred 12 h after the
injection of LPS (Fig. 1 B, a and e), but hemorrhage was
substantial by 24 h in gp49B /  mice (Fig. 1 C, a and e).
12 h after the injection of LPS, microscopic examination
revealed that fully occlusive venular thrombi, consisting
of neutrophils, platelets, and fibrin (Fig. 1 B, b and f),
were present in a significantly greater percentage of tissue
lengths in gp49B /  mice compared with gp49B /  mice
(6.8   1.6% vs. 1.4   0.65%, respectively; n   7; P  
0.01). 24 h after the injection of LPS, the increase in
occlusive thrombi in gp49B /   mice compared with
gp49B /  mice (Fig. 1 C, b and f) was not quantitated be-
cause of the confounding effect of the intense hemor-
rhage in gp49B /  mice.
The prominence of neutrophils in the thrombohemor-
rhagic response (Fig. 1, B and C, c and g) led to an enu-
meration of the number of neutrophils in tissue sections. 2
and 6 h after the injection of LPS, few neutrophils had ex-
travasated from the blood into the tissue in either gp49B / 
or gp49B /  mice (Fig. 1 D). However, after 12 h, there
were significant 5- and 12-fold increases in neutrophils in
the ears of both gp49B /  and gp49B /  mice, respectively,
compared with 6 h, and the number of neutrophils in
gp49B /  mice after the injection of LPS was significantly
greater than that in gp49B /  mice. 24 h after the injection
of LPS, the number of neutrophils in the ears of gp49B / 
and gp49B /  mice increased compared with 12 h, and the
number of neutrophils continued to be significantly higher
in gp49B /  mice compared with gp49B /  mice. In con-
trast, the numbers of neutrophils in the peripheral blood of
gp49B /  and gp49B /  mice 24 h after i.d. injection of
LPS were not significantly different (3,331   332 vs. 3,484  
480 per  l, respectively; n   8; P   0.80).
Because earlier studies revealed that mast cells in the ears
of gp49B /  mice were hyperresponsive to degranulation
by IgE-dependent passive cutaneous anaphylaxis or SCF as
assessed by ear swelling and tissue histology (11, 12), these
assays were also performed in response to LPS. Histologic
analyses showed no significant difference in the number
of intact (nondegranulating) mast cells in gp49B /  and
gp49B /  mice 2 h after LPS injection (3.9   0.3 and
3.7   0.03 intact mast cells/unit length, respectively; n   3
in one experiment; P   0.4), or at 6 (n   3 in one experi-
ment), 12 (n   7 in two experiments), or 24 (n   10 in
three experiments) h after injection. Early net tissue swell-
ing as assessed with calipers was not significantly different in
gp49B /  and gp49B /  mice 1 h after injection with LPS
(6.0   1.6 and 5.2   2.4   10 2 mm, respectively; n   6
gp49B /  and n   5 gp49B /  mice in two experiments;
P   0.8), and there were no significant differences at 2, 4,
or 8 h (all P   0.3) after injection in the same two experi-
ments.
Because mast cells as well as other gp49B1-expressing
cell types elaborate cytokines and chemokines, the amounts
of several of these mediators were assessed in extracts pre-
pared from the ears of mice 2 h after the injection of LPS,
the time point of their maximal values. There were no sig-
nificant differences between gp49B /  and gp49B /  mice
in the respective levels of IL-1  (12   2 vs. 14   4 pg/mg;
n   3 from one experiment), KC (31   2 vs. 32   1
pg/mg; n   6 from two experiments; P   0.7), MCP-1
(21   0.9 vs. 22   2 pg/mg; n   6 from two experiments;
P   0.6), MIP-1  (39   0.4 vs. 39   0.4 pg/mg; n   6
from two experiments; P   0.9), MIP-2 (16   1 vs. 17  
1 pg/mg; n   6 from two experiments; P   0.5), or TNF- 
(1.7   0.1 vs. 1.8   0.1 pg/mg; n   8 from three experi-
ments; P   0.3).
Role of Neutrophils in LPS-induced Hemorrhage in gp49B   
Mice. gp49B /  mice were depleted of neutrophils by an
i.p. injection of 100  g anti–Gr-1 24 h before the i.d. injec-
tion of 50  g LPS. Anti–Gr-1 elicited a 97% decrease in theT
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number of peripheral blood neutrophils measured 24 h after
the injection of LPS compared with mice injected i.p. with
saline (Fig. 2 A). Moreover, treatment of gp49B /  mice
with anti–Gr-1 caused a  95% decrease in the number of
neutrophils in the ears 24 h after the injection of LPS com-
pared with mice treated i.p. with saline (Fig. 2 B). Treat-
ment of mice with an i.p. injection of isotype-matched neg-
ative control Ig instead of anti–Gr-1 before LPS gave results
comparable to those with the injection of saline (unpub-
lished data). Importantly, as assessed both macroscopically
(Fig. 2 C) and microscopically (unpublished data), the hem-
orrhagic response to LPS did not occur in the absence of
neutrophils (0/11 vs. 11/11 for gp49B /  mice treated or
not treated with anti–Gr-1, respectively).
Role of Adhesion Molecules. gp49B /  mice were in-
jected i.v. with 100  g anti-CD18 or anti-CD54 2 h be-
fore the i.d. injection of LPS. Neither treatment reduced
significantly the number of neutrophils in the peripheral
blood 24 h after LPS injection compared with mice that re-
ceived isotype-matched negative control Ab (Fig. 3 A).
The numbers of neutrophils in ear tissue sections from
mice treated with anti-CD18 or anti-CD54 were both de-
creased by  45% compared with those from mice that re-
ceived negative control Ab (Fig. 3 B). Nevertheless, mac-
roscopic hemorrhage was substantially inhibited in five of
five gp49B /  mice treated with anti-CD18 and in three of
three mice treated with anti-CD54 (Fig. 3 C). Macroscopic
hemorrhage was not inhibited in eight control mice treated
with rat IgG2a (isotype-matched negative control for anti-
CD18), rat IgG2b (isotype-matched negative control for
anti-CD54), or saline.
Expression of gp49B1 on Neutrophils and Up-regulation by
LPS. The constitutive and LPS-induced expression of
gp49B1 on both peripheral blood and bone marrow neu-
trophils was assessed by cytofluorographic analysis with the
gp49B1-specific mAb B23.1 (16). Blood leukocytes were
stained with Alexa-labeled mAb B23.1 and neutrophils
were identified by simultaneous staining with PE-labeled
anti–Gr-1. Essentially, all anti–Gr-1  cells in the peripheral
blood (Fig. 4 A) and bone marrow (Fig. 4 B) of naive
gp49B /  mice were also gp49B1 . Furthermore, an in-
crease in the intensity of staining was apparent 1 h after the
i.d. injection of LPS, reached a plateau by 8 h (unpublished
data), and was maintained at 24 h (Fig. 4, A and B). 24 h
after the injection of LPS, the mean fluorescence intensities
of peripheral blood and bone marrow neutrophils from
Figure 2. Effects of neutrophil depletion on LPS-
induced hemorrhage in gp49B    mice. gp49B /  mice
were injected i.p. with saline or 100  g anti–Gr-1 24 h
before the i.d. injection of 50  g LPS. 24 h later,
peripheral blood was collected and the neutrophil
count was determined with an automated cell counter
(A). The number of neutrophils in tissue cross sections
(B) was determined as described for Fig. 1 D. Data are
expressed as mean   SEM, n   8 (A) or n   4 (B).
Macroscopic hemorrhage is illustrated for four mice
from one experiment (C), representative of three experi-
ments with a total of 11 mice in each treatment group.T
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gp49B /  mice had each increased approximately fourfold
compared with mice injected with saline. No mAb B23.1-
mediated staining was detected on peripheral blood or
bone marrow neutrophils from gp49B /  mice (unpub-
lished data), implicating the absence of gp49B1 in the neu-
trophil-dependent thrombohemorrhagic response to LPS
in gp49B /  mice.
Role of the Coagulation Pathway. gp49B /  mice were
given 2 mg of the anticoagulant warfarin intragastrically 1 h
before and 2 h after the LPS injection. Warfarin completely
inhibited the macroscopic and microscopic hemorrhagic
response in five of six gp49B /  mice, whereas vehicle con-
trol did not inhibit hemorrhage in three of three mice. The
effect of warfarin was not the result of neutrophil depletion
because the numbers of neutrophils in the peripheral blood
(3,660   900 vs. 2,833   450 per  l; n   5 and 8, respec-
tively; P   0.38) and ears (10.2   1.5 vs. 14.7   1.5 per
unit length; n   5 and 3, respectively; P   0.10) of LPS-
treated gp49B /  mice were not significantly different with
or without warfarin treatment, respectively. Thus, the co-
agulation pathway is critical to the LPS-induced micro-
angiopathy in the injected ear of gp49B /  mice.
Discussion
We have previously shown that gp49B1 constitutively
inhibits adaptive inflammation elicited by Ig-dependent
mast cell activation in vivo (11). Here we report that
gp49B1 is also expressed on neutrophils and suggest that
it inhibits neutrophil-dependent innate inflammation in-
duced by LPS. A single i.d. injection of LPS in the gp49B / 
mice resulted in a macroscopic thrombohemorrhagic re-
sponse that was essentially absent from gp49B /  mice (Fig.
1). Assessment of the requirements for the LPS-elicited le-
sion identified a role for the neutrophil (Fig. 2) and its inte-
grin-mediated endothelial cell interactions (Fig. 3), as well
as for the blood coagulation system. These are the essential
components of the classic LSR, which in normal mice re-
quires an i.d. priming dose of 7.5–50  g LPS followed by a
systemic challenge dose of 30–150  g LPS 18–24 h later
(18, 19). Because we found that the neutrophils of normal
mice constitutively express gp49B1 and that its expression
on neutrophils is up-regulated by the i.d. injection of LPS
(Fig. 4), the exaggerated microangiopathy of gp49B / 
mice to i.d. LPS revealed gp49B1 as a negative regulator of
LPS-mediated, neutrophil-dependent tissue injury.
gp49B1 is also expressed on mast cells (8) and macro-
phages (9) but, in contrast with our previous findings for
mast cell activation-dependent inflammation elicited by
Figure 3. Effects of blocking adhesion molecules on LPS-induced
hemorrhage in gp49B    mice. gp49B /  mice were injected i.v. with 100
 g anti-CD18, anti-CD54, or isotype-matched negative control Ig (rat
IgG2a and rat IgG2b, respectively) 2 h before the i.d. injection of 35  g
LPS. 24 h later, peripheral blood (A) and ear tissue (B) samples were analyzed
for neutrophil numbers and macroscopic hemorrhage (C) as described for
Fig. 2. Data are expressed as mean   SEM, n   3 (A and B). Hemorrhage
illustrated in C is representative of two experiments with a total of five
and three mice treated with anti-CD18 and anti-CD54, respectively.
*, significant difference between mice injected i.p. with IgG2a versus
anti-CD18.
Figure 4. Flow cytometric analysis of the expression of gp49B1 on
peripheral blood and bone marrow neutrophils. gp49B /  mice were
injected i.d. with saline (dotted line) or with 50  g LPS (filled curve and
solid line). 24 h later, peripheral blood (A) and bone marrow (B) cells
were stained with PE-labeled anti–Gr-1 and either Alexa-labeled mAb
B23.1 anti-gp49B1 (dotted and solid lines) or Alexa-labeled isotype-
matched negative control IgM (filled curve). Data are presented as histo-
grams of the Alexa fluorescence of anti–Gr-1  cells and are representative
of 5 experiments with a total of 10 mice in each group.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
Zhou et al. 1249
IgE-dependent passive cutaneous anaphylaxis or SCF (11,
12), gp49B /  mice did not exhibit more mast cell degran-
ulation and early tissue swelling in response to LPS. Fur-
thermore, the tissue levels of cytokines and chemokines
produced by and/or active on gp49B1-expressing cells (IL-
1 , KC, MCP-1, MIP-1 , MIP-2, and TNF- ; references
20–25) were not significantly different in extracts prepared
from the ears of gp49B /  and gp49B /  mice 2 h after LPS
injection, the time of maximal production of these media-
tors. Taken together, the data suggest that the LSR exhib-
ited by gp49B /  mice is not a result of increased exocytosis
of tissue-resident mast cells or cytokine/chemokine gener-
ation by macrophages or other cell types, but rather, a
heightened activation response of neutrophils. Neverthe-
less, in the absence of a direct demonstration of increased
neutrophil activation in situ, a contribution from the ab-
sence of gp49B1 on cells other than neutrophils in the gen-
eration of the LSR after a single LPS injection cannot be
entirely ruled out.
The essential role of intravascular neutrophils in the clas-
sic LSR (18) has been defined in terms of the adhesive
functions of  2 integrins and ICAM-1 (15). Neutrophils
contribute to the pathology of the classic LSR by enlarging
the size of thrombi when aggregated with each other and
enmeshed with platelets and fibrin, and they provide firm
adhesion of the thrombi to the endothelium via a  2 inte-
grin–ICAM-1 interaction. The resulting stasis in blood
flow leads to hypoxia that causes the disintegration of the
blood vessel endothelium and ensuing hemorrhage. Fur-
thermore, LPS-activated neutrophils that are immobilized
in blood vessels release mediators such as elastase and super-
oxide that are toxic to endothelial cells. Indeed, the classic
LSR is inhibited by a protease inhibitor and vascular dam-
age similar to the LSR is induced by the injection of lyso-
somal extracts from neutrophils (26, 27).
The induction of hemorrhage in gp49B /  mice 24 h af-
ter a single i.d. injection of LPS (Fig. 1 C) was preceded at
12 h by the occlusion of significantly more venules with
thrombi consisting of neutrophils, platelets, and fibrin com-
pared with gp49B /  mice (Fig. 1 B). In addition, there
were significantly more neutrophils in the tissue of gp49B / 
mice both 12 and 24 h after injection of LPS (Fig. 1 D).
The greater amount of tissue neutrophilia did not simply
represent the availability of more neutrophils for diapedesis
through blood vessels, because the numbers of peripheral
blood neutrophils in gp49B /  and  gp49B /  mice were
not significantly different 24 h after injection of the animals
with LPS. We also found that mouse peripheral blood neu-
trophils express CD18, CD11b, and CD54 (unpublished
data). The levels of these molecules were up-regulated after
the i.d. injection of LPS, but there were no differences in
the levels of their expression in the gp49B /  and gp49B / 
mice. Nevertheless, that neutrophils were required for the
hemorrhagic response to i.d. LPS in gp49B /  mice was es-
tablished by attenuation of the lesion with their depletion
(Fig. 2) and was related to their adhesion function. Intra-
venous provision of the anti-CD18 or anti-CD54 2 h before
the i.d. injection of LPS inhibited the hemorrhagic re-
sponse at 24 h (Fig. 3 C) without depleting blood or ear
neutrophils (Fig. 3, A and B), suggesting that increased
avidity of one or more  2 integrins for ICAM-1 in
gp49B /  mice is a key mechanistic step. We consider the
greater tissue neutrophilia in gp49B /  mice to be a sec-
ondary manifestation of this effect. Anti-CD11a did not in-
hibit hemorrhage in gp49B /  mice, even though CD11a is
expressed on essentially all mouse leukocytes except mast
cells. It was not possible to assess the role of CD11b be-
cause the injection of anti-CD11b depleted peripheral
blood neutrophils and reiterated the inhibitory effect of
anti–Gr-1. In rabbits, the classic LSR is inhibited by anti-
CD54, anti-CD11b, and anti-CD18, but not by anti-
CD11a, under conditions in which neutrophils were still
present in the vasculature as determined histologically (15).
gp49B1 is expressed on mast cells, macrophages, NK cells,
and T cells (8, 28–31), and mouse bone marrow and splenic
neutrophils bind a mAb directed to an epitope shared by
gp49A and gp49B1 (32). Using the gp49B1-specific mAb
B23.1 (11, 16), we now show that peripheral blood and
bone marrow neutrophils not only constitutively express this
inhibitory receptor but also up-regulate its expression after
the i.d. injection of LPS (Fig. 4). The molecule that bound
mAb B23.1 on the surface of peripheral blood neutrophils
from LPS-treated mice was full-length gp49B1 as assessed by
immunoprecipitation with mAb B23.1 followed by degly-
cosylation, SDS-PAGE, and immunoblotting with anti-
gp49B302–313 (8, 16, and unpublished data).
The presence of fibrin and platelets in the occluding
thrombi of LPS-treated gp49B /  mice suggested a contri-
bution of the blood coagulation pathway, as noted by others
for the classic LSR (33). That the administration of the anti-
coagulant warfarin inhibited the hemorrhagic response in
gp49B /  mice to i.d. LPS without decreasing the number
of peripheral blood or ear tissue neutrophils indicates that
the coagulation pathway is essential to the vasculopathy.
The characteristic involvement of the coagulation cascade in
the classic LSR may reflect LPS-mediated activation of the
pathway through the production of tissue factor by endo-
thelial cells and mononuclear phagocytes (34). The forma-
tion of a complex between tissue factor and factor VII ini-
tiates fibrin formation, and administration of anti–factor VII
before the systemic dose of LPS inhibits the classic LSR
(33). Hence, for both the single-dose LSR in gp49B / 
mice and the classic LSR, neutrophils and the coagulation
system are both necessary, but neither alone is sufficient.
The LSR is a model for thrombohemorrhagic vasculopa-
thy that can occur in response to infection with Gram-neg-
ative bacteria, such as during meningococcal sepsis (35, 36).
Furthermore, some of the characteristics of the LSR de-
scribed above occur in vasculitic syndromes initiated by im-
mune complexes and complement or through unknown
etiologies (36, 37). In addition, the LSR resembles in many
respects the generalized Shwartzman reaction, in which
both doses of LPS are given systemically, resulting in a  2
integrin–dependent, lethal thrombohemorrhagic syndrome
that is a model for the disseminated intravascular coagula-
tion that may occur during septic shock (37). Our findingsT
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provide the first presumptive evidence of counterregulation
of the response to a TLR agonist by an ITIM-bearing re-
ceptor in vivo. This conceivably reflects the recruitment of
src homology type 2 domain-containing phosphatase 1 by
the ITIMs of gp49B1, leading to reversal of LPS-induced
tyrosine phosphorylation (38–40). Because gp49B1 is the
closest mouse analogue of the human ITIM-bearing recep-
tor termed leukocyte Ig-like receptor 5 (or Ig-like transcript
3; references 41–43), our results suggest that the expression
of leukocyte Ig-like receptor 5 and/or other inhibitory re-
ceptors on myeloid cells may contribute to the outcome of
innate immune responses in human inflammatory condi-
tions. Moreover, the findings presented here when coupled
with our previous studies establish that gp49B1 inhibits a
functionally diverse group of activating receptors involved
in both adaptive and innate immune responses.
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